Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06752512 · ClinicalTrials.gov registry record · NA
Remote Temperature Monitoring of Patients At Risk for Developing Fever
A NA study of Cancer and Fever, sponsored by AION Biosystems.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT06752512 is a NA study of Cancer and Fever that is actively recruiting participants, run by AION Biosystems. The registered enrollment target is 150 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06752512, a NA study of Cancer and Fever, is actively recruiting participants, sponsored by AION Biosystems.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this program is to evaluate remote temperature monitoring in cancer patients at risk of fever and infection due to chemotherapy treatment. The main questions it aims to answer are: * does remote temperature monitoring reduce the number of days spent inpatient * what out-of-pocket cost can a patient expect to incur for participating in remote temperature monitoring * the number of billable CPT codes that will be generated by providing remote temperature monitoring Researchers will compare compliant and non-compliant patients to assess if compliance with remote temperature monitoring is associated with a decrease in the number of days spent inpatient. Patients will * wear the thermometer for the duration of their participation in the study * have their temperature monitored continuously * receive alerts on their phone when their temperature exceeds a threshold for a sustained duration, configurable by their physician * respond to texts or calls from remote monitors when an alert is triggered
Conditions Studied
Interventions
- DEVICE Remote Patient Monitoring
Study Locations (1)
New York
- Ellis Hospital - Schenectady
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2023-08-09 |
| Est. Completion | 2025-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06752512
The ClinicalTrials.gov registry entry for NCT06752512 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (96% lower). The listed sponsor is AION Biosystems, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Remote Patient Monitoring is the first listed.
NCT06752512 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06752512 about?
NCT06752512 is a clinical study titled "Remote Temperature Monitoring of Patients At Risk for Developing Fever". The purpose of this program is to evaluate remote temperature monitoring in cancer patients at risk of fever and infection due to chemotherapy treatment. The main questions it aims to answer are: * does remote temperature monitoring reduce the number of days spent inpatient * what out-of-pocket cos...
What is the current status of trial NCT06752512?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2023-08-09. Estimated completion is 2025-01.
What conditions does trial NCT06752512 study?
This clinical trial studies the following conditions: Cancer, Fever, Remote Patient Monitoring.
What interventions are being tested in trial NCT06752512?
The interventions under investigation include: Remote Patient Monitoring (DEVICE).
Who is sponsoring clinical trial NCT06752512?
This trial is sponsored by AION Biosystems, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06752512 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.